After learning a few things recently, I see Zagadat definitely wasn’t moving blindly on IIL. IIL is Ghana’s leading IV fluids/small-volume injectable manufacturer, has a sizeable domestic market share, and exports to Côte d’Ivoire, Burkina Faso, Togo (for now) & sole scale local producer — that makes it a genuine import-substitution moat, which adds to Zagadat’s broader African ambitions. New factory planned too. 6-12 months from now you’d wish you invested or invested more. Interesting times!